Where does ResnENT, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ResnENT, LLC ranks #20,318 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ResnENT, LLC hold?

ResnENT, LLC holds 14 US utility patents granted between 2019 and 2025, spanning 4 technology areas.

What is ResnENT, LLC's Innovation Score?

ResnENT, LLC has an Innovation Score of 49.6 out of 100 (top 14% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ResnENT, LLC focus on?

ResnENT, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 13 patents, ranking #1,352 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is ResnENT, LLC's patent grant rate increasing or decreasing?

ResnENT, LLC's recent grant velocity is +800% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for ResnENT, LLC's patents?

ResnENT, LLC's patents average 21.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the ResnENT, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

ResnENT, LLC

USPTO PatentsView assignee record - 14 granted patents across 4 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Resnent ranks #20,318 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 4 technology areas.

#20,318
of 49,997 US assignees by volume: Top 14%
by Innovation Score (49.6/100): 21.9
avg claims per patent: +800%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20318 · US Corporation #20,318 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,318/49,997
PHOTO-FINISH Regina Miracle…
CPC-NARROW A61B · 4 areas
INNOV-PAR 49.6/100
CLAIMS-DENSE 21.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +800% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Regina Miracle International (Group) Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Resnent’s 49.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (19%) Velocity 20.0 pts (40%) Breadth 7.1 pts (14%) Claim depth 13.2 pts (27%)

Qualcomm Incorporated · highest

85
ResnENT · this assignee

50
3D Lighting… · lowest

7

What this shows Resnent's Innovation Score is 49.6/100 (top 14% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Resnent?

Each dot is one of Resnent’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Resnent’s own 21.9 claims/patent is ABOVE the 15.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Resnent vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Resnent's grants concentrate

ResnENT, LLC is a focused PatentsView assignee: 4 CPC subclasses with 92.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2019. By volume, Resnent sits between Regina Miracle International (Group) Limited and ReveraGen BioPharma, Inc..

Resnent's three-year grant acceleration

ResnENT, LLC shows 8 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Regina Miracle In…

14
Relativity Space

14
Renu Therapy

14
Resense

14
Resonance Technol…

14
Respicardia

14
Retrieve Medical

14
Reveragen Biophar…

14
Resnent ◀

14

What this shows ResnENT holds 14 patents at rank #20,331, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ResnENT

By rank, the assignees closest to #20,331 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in ResnENT's primary technology class.

Resnent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

ResnENT, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	7.1%
2021	1	7.1%
2022	2	14.3%
2023	2	14.3%
2024	4	28.6%
2025partial year	4	28.6%

Which technologies does ResnENT, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 4

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ResnENT, LLC's patent record in context - here's where to go next.

ResnENT, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 92.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #20,318 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ResnENT, LLC against Regina Miracle International (Group) Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 49.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.